Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 399.18 million. The enterprise value is 480.47 million.

Market Cap	399.18M
Enterprise Value	480.47M

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 17.66 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	17.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.37%
Owned by Institutions (%)	52.55%
Float	12.07M

Valuation Ratios

The trailing PE ratio is 309.44 and the forward PE ratio is 31.17.

PE Ratio	309.44
Forward PE	31.17
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	372.46
EV / Sales	0.90
EV / EBITDA	10.32
EV / EBIT	15.11
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.49.

Current Ratio	1.42
Quick Ratio	0.72
Debt / Equity	0.49
Debt / EBITDA	2.55
Debt / FCF	n/a
Interest Coverage	1.68

Financial Efficiency

Return on equity (ROE) is 0.56% and return on invested capital (ROIC) is 5.41%.

Return on Equity (ROE)	0.56%
Return on Assets (ROA)	3.91%
Return on Invested Capital (ROIC)	5.41%
Return on Capital Employed (ROCE)	9.07%
Revenue Per Employee	11.81M
Profits Per Employee	28,667
Employee Count	45
Asset Turnover	1.05
Inventory Turnover	3.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.89% in the last 52 weeks. The beta is 0.49, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-39.89%
50-Day Moving Average	22.29
200-Day Moving Average	27.33
Relative Strength Index (RSI)	47.28
Average Volume (20 Days)	10,286

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 531.44 million and earned 1.29 million in profits.

Revenue	531.44M
Gross Profit	208.88M
Operating Income	31.80M
Pretax Income	5.16M
Net Income	1.29M
EBITDA	46.55M
EBIT	31.80M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 37.29 million in cash and 118.57 million in debt, giving a net cash position of -81.29 million or -4.60 per share.

Cash & Cash Equivalents	37.29M
Total Debt	118.57M
Net Cash	-81.29M
Net Cash Per Share	-4.60
Equity (Book Value)	240.44M
Book Value Per Share	n/a
Working Capital	59.18M

Full Balance Sheet

Cash Flow

Operating Cash Flow	38.36M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 39.30%, with operating and profit margins of 5.98% and 0.24%.

Gross Margin	39.30%
Operating Margin	5.98%
Pretax Margin	0.97%
Profit Margin	0.24%
EBITDA Margin	8.76%
EBIT Margin	5.98%
FCF Margin	n/a

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.32%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a